sarpogrelate sarpogrelate sarpogrelate (former developmental code names mci-9042, ls-187,118) is a drug which acts as an antagonist at the 5ht2a and 5-ht2b receptors. it blocks serotonin-induced platelet aggregation, and has applications in the treatment of many diseases including diabetes mellitus, buerger's disease, raynaud's disease, coronary artery disease, angina pectoris, and atherosclerosis. sarpogrelateclinical dataother namessarpogrelate, (−)-4-phenoxy]propan-2-yl]oxy-4-oxobutanoic acidahfs/drugs.cominternational drug namesatc codenoneidentifiers iupac name 4-phenoxy}methyl)ethoxy]-4-oxobutanoic acid cas number125926-17-2 ypubchem cid5160iuphar/bps210chemspider4976 nunii19p708e787chemblchembl52939 ncomptox dashboard (epa)dtxsid7048328 chemical and physical dataformulac24h31no6molar mass429.513 g·mol−13d model (jsmol)interactive image smiles cn(c)cc(coc1=cc=cc=c1ccc2=cc(=cc=c2)oc)oc(=o)ccc(=o)o inchi inchi=1s/c24h31no6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21h,11-14,16-17h2,1-3h3,(h,26,27) nkey:ffynavgjsyhhfo-uhfffaoysa-n n ny (what is this?) (verify)